Τετάρτη 4 Ιανουαρίου 2017

Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?

http:--highwire.stanford.edu-icons-exter https:--http://ift.tt/2bsbOVj

Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?

Haematologica. 2016 Mar;101(3):263-5

Authors: Pospisilova S, Sutton LA, Malcikova J, Tausch E, Rossi D, Montserrat E, Moreno C, Stamatopoulos K, Gaidano G, Rosenquist R, Ghia P, European Research Initiative on CLL (ERIC)

PMID: 26928246 [PubMed - indexed for MEDLINE]



http://ift.tt/2hPLw2B

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου